步长制药：获得布洛芬缓释胶囊药品注册证书

Core Viewpoint - The announcement by the company regarding the approval of Ibuprofen sustained-release capsules by the National Medical Products Administration indicates a significant development in its product portfolio, aimed at addressing various types of pain and fever associated with common illnesses [1] Company Summary - The company, Bicheng Pharmaceutical, has received a drug registration certificate for Ibuprofen sustained-release capsules from the National Medical Products Administration [1] - The approved indication for the drug includes relief from mild to moderate pain such as headaches, joint pain, migraines, toothaches, muscle pain, neuralgia, and dysmenorrhea, as well as fever caused by common colds or influenza [1] Industry Summary - The approval of this medication aligns with the growing demand for effective pain management solutions in the pharmaceutical industry, particularly for over-the-counter medications [1] - The introduction of Ibuprofen sustained-release capsules may enhance competition within the pain relief segment of the pharmaceutical market [1]